Founded on pioneering research and industry leadership, ARxIUM® is committed to overcoming the most complex challenges ...
As we look ahead to 2026, the operational demands on 340B programs are increasing across every dimension. Between the implementation of the 340B Rebate Model pilot and Maximum Fair Price (MFP) covered ...
Four drug manufacturers have announced plans to offer discounted drug prices to safety net providers under the federal 340B program via rebates instead of upfront discounts, despite the federal ...
Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...
In a May 15, 2025, opinion, Judge Dabney Friedrich of the US District Court for the District of Columbia denied drugmakers’ motions for summary judgment against the US Department of Health and Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results